Lv1
76 积分 2023-03-18 加入
Schizophrenia
1个月前
已完结
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
1个月前
已完结
Xanomeline/Trospium Chloride as an Adjunctive Treatment for a Patient With Treatment-Resistant Schizoaffective Disorder
1个月前
已关闭
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
2个月前
已完结
Comment on “A Real-World Pharmacovigilance Analysis of Lorlatinib-Associated Metabolic Effects Using the FDA Adverse Events Reporting System (FAERS) Database From 2013 to 2024” by Frey et al
2个月前
已关闭
Optimising treatment in Crohn's disease: is the main issue early versus late or biologic naive versus biologic experienced?
5个月前
已关闭
Ileal bile acid transporter inhibitors for cholestatic pruritus in primary biliary cholangitis
5个月前
已关闭
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Comment on “Postmarketing adverse events of tamoxifen in male and female patients with breast cancer”
5个月前
已完结
The risk of hypoventilation during bronchoscopy under oxygen and procedural sedation
7个月前
已关闭
皖公网安备34019202002308
